Siregar, G., R. Paramesh, R. Kumawat, P. D, and S. HA. “A prospective, interventional clinical study to evaluate the safety and efficacy of Liv.52 DS in the management of non-alcoholic fatty liver disease”. European Journal of Clinical and Experimental Medicine, vol. 19, no. 2, June 2021, pp. 129–136, doi:10.15584/ejcem.2021.2.3.